XTX Topco Ltd - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$427,105
+56.2%
296,601
+170.0%
0.07%
+49.0%
Q2 2023$273,522
-65.3%
109,848
-62.7%
0.05%
-70.3%
Q1 2023$788,703
+42.0%
294,292
+187.7%
0.16%
+39.8%
Q4 2022$555,391
+197.0%
102,282
+584.8%
0.12%
+156.5%
Q3 2022$187,000
-16.9%
14,937
-67.2%
0.05%
-50.0%
Q2 2022$225,00045,5560.09%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders